[go: up one dir, main page]

HK1034902A1 - Fluoxetine enteric pellets - Google Patents

Fluoxetine enteric pellets Download PDF

Info

Publication number
HK1034902A1
HK1034902A1 HK01105581A HK01105581A HK1034902A1 HK 1034902 A1 HK1034902 A1 HK 1034902A1 HK 01105581 A HK01105581 A HK 01105581A HK 01105581 A HK01105581 A HK 01105581A HK 1034902 A1 HK1034902 A1 HK 1034902A1
Authority
HK
Hong Kong
Prior art keywords
fluoxetine
layer
enteric
core
pharmaceutically acceptable
Prior art date
Application number
HK01105581A
Other languages
English (en)
Chinese (zh)
Other versions
HK1034902B (en
Inventor
N‧R‧安德森
R‧G‧哈里森
D‧F‧利奇
P‧L‧奥伦
Original Assignee
伊莱利利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1034902(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 伊莱利利公司 filed Critical 伊莱利利公司
Publication of HK1034902A1 publication Critical patent/HK1034902A1/xx
Publication of HK1034902B publication Critical patent/HK1034902B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK01105581.3A 1997-05-29 2001-08-10 Fluoxetine enteric pellets HK1034902B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use
US867196 1997-05-29

Publications (2)

Publication Number Publication Date
HK1034902A1 true HK1034902A1 (en) 2001-11-09
HK1034902B HK1034902B (en) 2006-03-17

Family

ID=

Also Published As

Publication number Publication date
BR9801989A (pt) 2000-02-08
NL1009259C2 (nl) 1998-12-01
NO982197D0 (no) 1998-05-14
FR2763846A1 (fr) 1998-12-04
IE980284A1 (en) 2000-07-12
SI9800128A (sl) 1999-02-28
TR199800937A2 (xx) 1999-10-21
US5910319A (en) 1999-06-08
RO120043B1 (ro) 2005-08-30
FI119971B (fi) 2009-05-29
DK176776B1 (da) 2009-08-10
SI9800128B (sl) 2000-04-30
CA2234826A1 (en) 1998-11-29
PE75399A1 (es) 1999-08-17
JPH10330253A (ja) 1998-12-15
HU9800882D0 (en) 1998-05-28
GB2325623B (en) 1999-04-14
CN1161109C (zh) 2004-08-11
MY118139A (en) 2004-09-30
LU90245B1 (fr) 2002-07-31
SE9801336D0 (sv) 1998-04-17
AR011728A1 (es) 2000-08-30
SG72805A1 (en) 2000-05-23
US5985322A (en) 1999-11-16
CH693018A5 (de) 2003-01-31
ITMI980908A1 (it) 1999-10-28
CO4940407A1 (es) 2000-07-24
USRE39030E1 (en) 2006-03-21
SE522914C2 (sv) 2004-03-16
FR2763846B1 (fr) 2001-05-18
TR199800937A3 (tr) 1999-10-21
LT4477B (lt) 1999-03-25
RS49827B (sr) 2008-08-07
RU2164405C2 (ru) 2001-03-27
HUP9800882A3 (en) 2000-07-28
ES2161574B1 (es) 2002-06-16
PT102152B (pt) 2000-09-29
LV12176B (lv) 1999-03-20
DE19823940B4 (de) 2010-04-29
BE1011925A3 (fr) 2000-03-07
FI980846L (fi) 1998-11-30
UA48193C2 (uk) 2002-08-15
LT98058A (en) 1998-10-26
CZ114398A3 (cs) 1998-12-16
GB9807939D0 (en) 1998-06-10
PL192293B1 (pl) 2006-09-29
TWI239838B (en) 2005-09-21
ES2161574A1 (es) 2001-12-01
ATA93198A (de) 2001-01-15
HUP9800882A2 (hu) 2000-03-28
NO982197L (no) 1998-11-30
PT102152A (pt) 1998-12-31
GB2325623A (en) 1998-12-02
CN1285189A (zh) 2001-02-28
SE9801336L (sv) 1998-11-30
LV12176A (lv) 1998-12-20
ZA983173B (en) 1999-10-15
NO317743B1 (no) 2004-12-13
GR980100188A (el) 1999-01-29
AT408068B (de) 2001-08-27
AU726690B2 (en) 2000-11-16
SV1998000052A (es) 1999-03-16
KR19980086622A (ko) 1998-12-05
JP3210288B2 (ja) 2001-09-17
FI980846A0 (fi) 1998-04-16
CZ290582B6 (cs) 2002-08-14
ID20343A (id) 1998-12-03
NZ330192A (en) 1999-08-30
CA2234826C (en) 2000-12-19
PL326134A1 (en) 1998-12-07
LU90245A1 (pt) 1998-11-30
CN1200924A (zh) 1998-12-09
IL124073A (en) 2002-02-10
YU16598A (en) 1999-11-22
KR100549473B1 (ko) 2006-03-23
CN1212834C (zh) 2005-08-03
AU6904898A (en) 1998-12-03
DE19823940A1 (de) 1998-12-03

Similar Documents

Publication Publication Date Title
CN1212834C (zh) 氟西汀肠溶微丸
JPH083035A (ja) 医薬の応答反応の増強
JPH08208471A (ja) 薬物反応の増強作用
US20110052647A1 (en) Antidepressant Oral Pharmaceutical Compositions
CN1638771A (zh) 3－[(2－{[4－(己氧羰基氨基－亚氨基－甲基)－苯基氨基]－甲基}－1－甲基－1h－苯并咪唑－5－羰基）－吡啶－2－基－氨基]－丙酸乙酯及其盐的口服施用的投药剂型
FR2673538A1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
CN1216467A (zh) 西沙必利的速释pH－非依赖性固体剂型
CN1135981C (zh) 硫酸吗啡微粒、其制备方法和药物制剂
CN1529587A (zh) 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物
HK1034902B (en) Fluoxetine enteric pellets
WO2011096953A1 (en) Oral antidepressant formulation with reduced excipient load
CN1250208C (zh) 氟西汀肠溶片
CN1228046C (zh) 氟西汀缓释片
MXPA98003636A (es) Granulos entericos de fluoxetina
IE83510B1 (en) Fluoxetine enteric pellets
CN1586481A (zh) 丙卡特罗滴丸剂及其制备方法
CN1795856A (zh) 一种含泰妥拉唑的药物制剂及制备方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130424